Date of dispatch of this notice: 28/11/2017
External Reference: 2017-228620
TED Reference: 2017/S 230-479224
Contract award notice
Information
Published
Contract award notice
Contract award notice
Results of the procurement procedure
Directive 2014/24/EU
Section I: Contracting authority
I.1)
Name and addresses
Health Service Executive (HSE)
N/A
Head Office
Naas
Millennium Park
IE
Contact person:
Sabrina Byrne
E-mail:
sabrina.byrne@hse.ie
NUTS code:
IE -
IRELAND
Main address:
http://www.hse.ie
Address of the buyer profile:
https://irl.eu-supply.com/ctm/Company/CompanyInformation/Index/461
I.2)
Joint procurement
The contract is awarded by a central purchasing body
I.4)
Type of the contracting authority
Body governed by public law
I.5)
Main activity
Health
Section II: Object
II.1)
Scope of the procurement
II.1.1)
Title
National Contract for Directly Acting Antiviral Medicines for GT3 Treatment in Hep C Programme
Reference number:
9464
II.1.2)
Main CPV code
33600000
-
Pharmaceutical products
II.1.3)
Type of contract
Supplies
II.1.4)
Short description
Contract for Directly Acting Antiviral Medicines for GT3 Treatment in Hep C Programme
II.1.6)
Information about lots
This contract is divided into lots:
no
II.1.7)
Total value of the procurement
Value excluding VAT:
2856000.00
EUR
II.2)
Description
II.2.2)
Additional CPV code(s)
33600000
-
Pharmaceutical products
II.2.3)
Place of performance
NUTS code:
IE -
IRELAND
Main site or place of performance:
Ireland
II.2.4)
Description of the procurement
The HSE wishes to establish a national contract for the provision of Directly Acting Antiviral (DAAs) medicines for use in provision of treatment to a limited number of GT3 patients to the end of 2017.
II.2.5)
Award criteria
Criteria below
Quality criterion
-
Name:
Quality
/
Weighting:
10%
Quality criterion
-
Name:
Contract Management
/
Weighting:
10%
Cost criterion
-
Name:
Cost
/
Weighting:
80%
II.2.11)
Information about options
Options:
no
II.2.13)
Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
no
II.2.14)
Additional information
The stated contract value is based on the highest tendered option received.
Section IV: Procedure
IV.1)
Description
IV.1.1)
Type of procedure
Open procedure
Accelerated procedure
Justification:
The accelerated procedure is justified as clinicians have identified a number of patients in urgent need of treatment using the GT3 regimen and the remaining budget available to the National Hepatitis C Treatment Programme for 2017 will allow limited access under existing commercial terms and reduce significantly the numbers of patients overall that can be treated.
IV.1.8)
Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement
: yes
IV.2)
Administrative information
IV.2.1)
Previous publication concerning this procedure
Notice number in the OJ S: 2017/S 190-388547
Section V: Award of contract
Contract No: 1
Title: National Contract for Direct Acting Antiviral Medicines for GT3 Treatment in Hep C Programme
V.2)
Award of contract
V.2.1)
Date of conclusion of the contract
01/11/2017
V.2.2)
Information about tenders
Number of tenders received:
7
The contract has been awarded to a group of economic operators
:
yesV.2.3)
Name and address of the contractor
Gilead Sciences Ireland UC
259755
Ida Business & Technology Park
Carrigtohill
IE
NUTS code:
IE -
IRELAND
The contractor is an SME : no
Abbvie Limited
510846
14 Riverwalk, Citywest Business Campus
Dublin
IE
NUTS code:
IE -
IRELAND
The contractor is an SME : no
V.2.4)
Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
3400000.00
EUR
Total value of the contract/lot:
2856000.00
EUR
Section VI: Complementary information
VI.4)
Procedures for review
VI.4.1)
Review body
The High Court
Four Courts
Dublin 7
IE